The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”

A phase III study has demonstrated that 6-month pasireotide treatment induced disease control with good safety in 15–26% of patients with Cushing’s disease (CD). The aim of the current study was to evaluate the 6-month efficacy and safety of pasireotide treatment according to the real-world evidence...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Endocrine
Main Authors: Pivonello, Rosario, Arnaldi, Giorgio, Scaroni, Carla, Giordano, Carla, Cannavò, Salvo, Iacuaniello, Davide, Trementino, Laura, Zilio, Marialuisa, Guarnotta, Valentina, Albani, Adriana, Cozzolino, Alessia, Michetti, Grazia, Boscaro, Marco, Colao, Annamaria
Formáid: Artigo
Teanga:Inglês
Foilsithe: Springer US 2019
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551343/
https://ncbi.nlm.nih.gov/pubmed/30968338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-018-1818-7
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla